Luxna Biotech

Osaka, Japan

Luxana Biotech is established to contribute to medical treatment for suffering patients, .

$1.7M raised

Sep 2024

Series C

Biotechnology Health Care Product Research

Top Investors

Mizuho CapitalOsaka University Venture CapitalSenshu Ikeda CapitalJapan Finance CorporationTohoku University Venture Partners

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Luxna Biotech

How much funding has Luxna Biotech raised?

Luxna Biotech has raised $1.7M in total funding. The most recent round was Series C. The last funding was announced in September 2024.

Who are Luxna Biotech's investors?

Luxna Biotech's investors include Mizuho Capital, Osaka University Venture Capital, Senshu Ikeda Capital, Japan Finance Corporation, Tohoku University Venture Partners.

Where is Luxna Biotech headquartered?

Luxna Biotech is headquartered in Osaka, Japan.

What does Luxna Biotech do?

Luxana Biotech is established to contribute to medical treatment for suffering patients, .

What stage is Luxna Biotech at?

Luxna Biotech is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 6, 2024.

MLA

"Luxna Biotech — Funding & Investors." VCBacked, September 6, 2024, https://www.vcbacked.co/company/luxna-biotech. Accessed June 4, 2026.

APA

VCBacked. (2024). Luxna Biotech — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/luxna-biotech

Wikipedia (cite web)

{{cite web |title=Luxna Biotech — Funding & Investors |url=https://www.vcbacked.co/company/luxna-biotech |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 6, 2024.